Ernexa Therapeutics Inc.
ERNA
$4.27
-$0.03-0.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.31M | 1.63M | 1.42M | 958.00K | 1.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.10M | 3.55M | 2.09M | 1.99M | 2.50M |
| Operating Income | -4.10M | -3.55M | -2.09M | -1.99M | -2.50M |
| Income Before Tax | -4.01M | -5.55M | -1.56M | -1.23M | -3.14M |
| Income Tax Expenses | -- | -40.00K | -62.00K | 6.00K | 3.00K |
| Earnings from Continuing Operations | -4.01M | -5.51M | -1.50M | -1.24M | -3.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.01M | -5.51M | -1.50M | -1.24M | -3.14M |
| EBIT | -4.10M | -3.55M | -2.09M | -1.99M | -2.50M |
| EBITDA | -4.10M | -3.54M | -2.08M | -1.98M | -2.48M |
| EPS Basic | -3.40 | -6.95 | -4.57 | -3.77 | -15.20 |
| Normalized Basic EPS | -2.14 | -2.76 | -3.02 | -3.74 | -9.47 |
| EPS Diluted | -3.40 | -6.95 | -4.57 | -3.77 | -15.20 |
| Normalized Diluted EPS | -2.14 | -2.76 | -3.02 | -3.74 | -9.47 |
| Average Basic Shares Outstanding | 1.18M | 792.00K | 330.30K | 329.00K | 207.00K |
| Average Diluted Shares Outstanding | 1.18M | 792.00K | 330.30K | 329.00K | 207.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |